Abstract
Background-A nitric oxide-independent response, possibly mediated by hyperpolarization, regulates vascular tone, acting as a compensatory mechanism in the presence of impaired nitric oxide availability. Cytochrome P450 2C9 (CYP 2C9) is a source of endothelium-derived hyperpolarizing factors and modulates tissue-type plasminogen activator (tPA) release from endothelial cells; however, no effect of hyperpolarization on fibrinolysis has been documented in humans. We aimed to assess the effect of sulfaphenazole, a specific CYP 2C9 inhibitor, on tPA release in normotensive subjects and patients with essential hypertension. Methods and Results-tPA release was measured in the forearm microcirculation of 56 normotensivesubjects and 57 patients with essential hypertension after bradykinin (0.015μg · 100 mL-1 · min-1) and acetylcholine (1.5 μg · 100 mL-1 · min-1) infusions, with or without sulfaphenazole (0.03 μg · 100 mL-1 · min-1). Bradykinin and acetylcholine infusions were repeated with NG-monomethyl-L-arginine (L-NMMA; 100 μg · 100 mL-1 · min-1) and/or sulfaphenazole. tPA release by bradykinin and acetylcholine was higher in normotensive subjects than in patients with essential hypertension (P<0.01). Sulfaphenazole (P<0.01) blunted bradykinin-induced but not acetylcholine-induced tPA release in both groups. In normotensive subjects, L-NMMA infusion reduced tPA release (P<0.01). When L-NMMA was coinfused with sulfaphenazole, tPA release induced by bradykinin, but not by acetylcholine, was further reduced (P<0.01). In patients with essential hypertension, tPA release by both agonists was unaffected by L-NMMA, but only bradykinininduced tPA release was blunted by sulfaphenazole, alone or with L-NMMA (P<001). Conclusions-Sulfaphenazole inhibits bradykinin-induced tPA release, which suggests a modulatory role of CYP 2C9-derived endothelium-derived hyperpolarizing factors in tPA release in humans. In patients with essential hypertension, tPA release depends exclusively on endothelium-derived hyperpolarizing factor, which is an ineffective compensatory mechanism in the presence of impaired nitric oxide availability.
| Original language | English |
|---|---|
| Pages (from-to) | 1625-1633 |
| Number of pages | 9 |
| Journal | Circulation |
| Volume | 119 |
| Issue number | 12 |
| DOIs | |
| State | Published - 31 Mar 2009 |
| Externally published | Yes |
Keywords
- Endothelium
- Endothelium-derived hyperpolarization factor
- Hypertension
- Nitric oxide
- Plasminogen activators
Fingerprint
Dive into the research topics of 'Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver